Biotech companies are struggling to navigate Trump’s new tariffs Many large drugmakers are exempt, but smaller firms say they need more guidance

https://www.statnews.com/2026/10/08/trump-tariffs-section-232-imported-prescription-drugs-challenge-biotech-companies/ By Chelsea CirruzzoOct. 8, 2026 Washington Correspondent